Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells
- PMID: 3308489
- DOI: 10.1002/eji.1830170926
Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells
Abstract
In vitro exposure of human peripheral blood mononuclear cells (PBMC) to interleukin 2 results in the generation of lymphokine-activated killer (LAK) cells. Such LAK cells exhibit cytotoxicity against a spectrum of tumor target cell lines whereas they apparently do not affect normal tissues. In this report we show that PBMC that have been activated with T cell growth factor lyse trypsinized human umbilical cord venous endothelial cells as well as endothelial cell monolayers in a dose-dependent manner. Microscopic analysis showed that during the 4-h incubation period cell clumps containing detached endothelial cells and LAK cells were formed. When these clumps were evaluated with trypan blue the endothelial cells stained positive whereas LAK cells excluded the dye. No lysis occurred when fresh PBMC were added to target endothelial cells. The endothelial cell kill could not be blocked with an anti-LFA-1 antibody nor with intact OKT3 or F(ab')2 fragments of WT32. We conclude that lymphokine-activated PBMC exhibit cell-mediated endothelial cell detachment and lysis.
Similar articles
-
Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.Immunology. 1988 Sep;65(1):107-12. Immunology. 1988. PMID: 3263311 Free PMC article.
-
Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.J Clin Lab Immunol. 1993;40(2):47-60. J Clin Lab Immunol. 1993. PMID: 7932628
-
Interferon-gamma protects human endothelial cells from lymphokine-activated killer cell-mediated lysis.Eur J Immunol. 1988 Nov;18(11):1839-42. doi: 10.1002/eji.1830181129. Eur J Immunol. 1988. PMID: 3144455
-
Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373
-
Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.J Natl Cancer Inst. 1985 Jul;75(1):67-75. J Natl Cancer Inst. 1985. PMID: 2989604
Cited by
-
Cytolytic activity in T cell clones derived from human synovial rheumatoid membrane: inhibition by synovial fluid.Clin Exp Immunol. 1990 Dec;82(3):499-503. doi: 10.1111/j.1365-2249.1990.tb05479.x. Clin Exp Immunol. 1990. PMID: 2148285 Free PMC article.
-
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE).Clin Exp Immunol. 1991 May;84(2):238-44. doi: 10.1111/j.1365-2249.1991.tb08155.x. Clin Exp Immunol. 1991. PMID: 2025951 Free PMC article.
-
Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.Clin Exp Immunol. 1991 Mar;83(3):352-8. doi: 10.1111/j.1365-2249.1991.tb05642.x. Clin Exp Immunol. 1991. PMID: 1848487 Free PMC article.
-
Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.Clin Exp Immunol. 1995 Oct;102(1):144-51. doi: 10.1111/j.1365-2249.1995.tb06648.x. Clin Exp Immunol. 1995. PMID: 7554381 Free PMC article.
-
Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells.Immunology. 1988 Sep;65(1):107-12. Immunology. 1988. PMID: 3263311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources